170 related articles for article (PubMed ID: 21565804)
1. Whole-genome comparison of two Acinetobacter baumannii isolates from a single patient, where resistance developed during tigecycline therapy.
Hornsey M; Loman N; Wareham DW; Ellington MJ; Pallen MJ; Turton JF; Underwood A; Gaulton T; Thomas CP; Doumith M; Livermore DM; Woodford N
J Antimicrob Chemother; 2011 Jul; 66(7):1499-503. PubMed ID: 21565804
[TBL] [Abstract][Full Text] [Related]
2. Genome sequences of two multidrug-resistant Acinetobacter baumannii strains isolated from a patient before and after treatment with tigecycline.
Hua X; Zhou H; Jiang Y; Feng Y; Chen Q; Ruan Z; Yu Y
J Bacteriol; 2012 Dec; 194(24):6979-80. PubMed ID: 23209232
[TBL] [Abstract][Full Text] [Related]
3. A Novel Genome-Editing Platform for Drug-Resistant Acinetobacter baumannii Reveals an AdeR-Unrelated Tigecycline Resistance Mechanism.
Trebosc V; Gartenmann S; Royet K; Manfredi P; Tötzl M; Schellhorn B; Pieren M; Tigges M; Lociuro S; Sennhenn PC; Gitzinger M; Bumann D; Kemmer C
Antimicrob Agents Chemother; 2016 Dec; 60(12):7263-7271. PubMed ID: 27671072
[TBL] [Abstract][Full Text] [Related]
4. Effects of In vivo Emergent Tigecycline Resistance on the Pathogenic Potential of Acinetobacter baumannii.
Hornsey M; Wareham DW
Sci Rep; 2018 Mar; 8(1):4234. PubMed ID: 29523824
[TBL] [Abstract][Full Text] [Related]
5. In vitro activities of tigecycline, minocycline, and colistin-tigecycline combination against multi- and pandrug-resistant clinical isolates of Acinetobacter baumannii group.
Arroyo LA; Mateos I; González V; Aznar J
Antimicrob Agents Chemother; 2009 Mar; 53(3):1295-6. PubMed ID: 19075049
[No Abstract] [Full Text] [Related]
6. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii.
Principe L; D'Arezzo S; Capone A; Petrosillo N; Visca P
Ann Clin Microbiol Antimicrob; 2009 May; 8():18. PubMed ID: 19460166
[TBL] [Abstract][Full Text] [Related]
8. OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.
Cakirlar FK; Ciftci IH; Gonullu N
Clin Lab; 2015; 61(7):741-7. PubMed ID: 26299073
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Park GC; Choi JA; Jang SJ; Jeong SH; Kim CM; Choi IS; Kang SH; Park G; Moon DS
Ann Lab Med; 2016 Mar; 36(2):124-30. PubMed ID: 26709259
[TBL] [Abstract][Full Text] [Related]
10. Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase.
Chen Q; Li X; Zhou H; Jiang Y; Chen Y; Hua X; Yu Y
J Antimicrob Chemother; 2014 Jan; 69(1):72-6. PubMed ID: 23928024
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of tigecycline against Acinetobacter baumannii isolates from a teaching hospital in Malaysia.
Dhabaan GN; AbuBakar S; Shorman MA; Hassan H
J Chemother; 2012 Apr; 24(2):87-92. PubMed ID: 22546763
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii clinical isolates.
Ricciardi R; Ricciardi AM; Danzi G
Infez Med; 2009 Dec; 17(4):236-9. PubMed ID: 20046104
[TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan.
Liu JW; Wang LS; Cheng YJ; Hsu GJ; Lu PL; Liu YC; Chen CM; Lee CM; Sun W; Jang TN; Chiang PC; Chuang YC; Lin HC; Shi ZY; Kung HC; Huang CH; Tsao SM; Lu CT; Liao CH; Hsueh PR
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 3():S188-91. PubMed ID: 19013353
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of Resistance, Clonal Expansion, and Increasing Prevalence of Acinetobacter baumannii Strains Displaying Elevated Tigecycline MIC Values in Latin America.
Costello SE; Gales AC; Morfin-Otero R; Jones RN; Castanheira M
Microb Drug Resist; 2016 Jun; 22(4):253-8. PubMed ID: 26716768
[TBL] [Abstract][Full Text] [Related]
15. [In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates].
Nayman Alpat S; Aybey AD; Akşit F; Ozgüneş I; Kiremitçi A; Usluer G
Mikrobiyol Bul; 2010 Oct; 44(4):641-5. PubMed ID: 21063976
[TBL] [Abstract][Full Text] [Related]
16. Bacterial peritonitis due to Acinetobacter baumannii sequence type 25 with plasmid-borne new delhi metallo-β-lactamase in Honduras.
Waterman PE; McGann P; Snesrud E; Clifford RJ; Kwak YI; Munoz-Urbizo IP; Tabora-Castellanos J; Milillo M; Preston L; Aviles R; Sutter DE; Lesho EP
Antimicrob Agents Chemother; 2013 Sep; 57(9):4584-6. PubMed ID: 23817381
[TBL] [Abstract][Full Text] [Related]
17. Complete genome sequence of Acinetobacter baumannii MDR-TJ and insights into its mechanism of antibiotic resistance.
Huang H; Yang ZL; Wu XM; Wang Y; Liu YJ; Luo H; Lv X; Gan YR; Song SD; Gao F
J Antimicrob Chemother; 2012 Dec; 67(12):2825-32. PubMed ID: 22952140
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology of multidrug-resistant Acinetobacter baumannii isolates in a university hospital in Nepal reveals the emergence of a novel epidemic clonal lineage.
Shrestha S; Tada T; Miyoshi-Akiyama T; Ohara H; Shimada K; Satou K; Teruya K; Nakano K; Shiroma A; Sherchand JB; Rijal BP; Hirano T; Kirikae T; Pokhrel BM
Int J Antimicrob Agents; 2015 Nov; 46(5):526-31. PubMed ID: 26362951
[TBL] [Abstract][Full Text] [Related]
19. Whole-genome shotgun sequences of seven colistin-resistant Acinetobacter baumannii isolates from bacteraemia.
Vijayakumar S; S BA; Kanthan K; Veeraraghavan B
J Glob Antimicrob Resist; 2018 Mar; 12():155-156. PubMed ID: 29410025
[TBL] [Abstract][Full Text] [Related]
20. Molecular identification of tigecycline- and colistin-resistant carbapenemase-producing Acinetobacter baumannii from a Greek hospital from 2011 to 2013.
Mavroidi A; Likousi S; Palla E; Katsiari M; Roussou Z; Maguina A; Platsouka ED
J Med Microbiol; 2015 Sep; 64(9):993-997. PubMed ID: 26297501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
